Etiological Agents of Urinary Tract Infection (UTI)

Authors

  • Rana Thamer Hadi Alkhafaji  Department of Studies and Research in Microbiology, Mangalore University, Post Graduate Center, Kodagu, Karnataka, India
  • M. Jayashankar  Department of Studies and Research in Microbiology, Mangalore University, Post Graduate Center, Kodagu, Karnataka, India

DOI:

https://doi.org/10.32628/IJSRST22925

Keywords:

Urinary Tract Infection (UTI), UTI Etiological, Gram Negative Uropathogens, Gram- Positive Uropathogens

Abstract

Urinary tract infection is one of the most common infectious diseases and has a high financial burden on society. The occurrence of urinary tract infection acquired by the population is higher in young women, almost half of all women will have at least one UTI episode during their lifetime, and about 1 in 3 women will have at least one UTI episode at the age of 24 years. Urinary tract infection increases with age for both sexes. It is estimated that 10 percent of men and 20 percent of women over 65 years of age have bacterial symptoms. Worldwide, Community-associated UTI (CAUTI) prevalence is 0.7% and the main risk factors are age, sexual activity, history of urinary tract infection, and diabetes. UTI is caused by Gram-negative and Gram-positive bacteria, where more than 95 % of UTI cases are caused by bacteria. Gram-negative organisms, primarily from the Enterobacteriaceae family, are responsible for UTI. It includes Escherichia coli (74.20 %), Enterococcus spp (5.30 %), Staphylococcus saprophyticus (1.40 %) Pseudomonas spp. (3.20 %), Klebsiella pneumoniae (6.20 %), and Proteus mirabilis (2.00 %) are among the bacteria that cause UTIs, with other bacteria accounting for 8.70 % .The aim of this review is to provide a summary and critical evaluation of the published evidence about the etiological agents of urinary tract infection.

References

  1. Foxman, B. (2010). The epidemiology of urinary tract infection. Nature Reviews Urology, 7(12), 653-660.
  2. Grabe, M., Bjerklund-Johansen, T. E., Botto, H., Çek, M., Naber, K. G., Tenke, P., & Wagenlehner, F. (2015). Guidelines on urological infections. European association of urology, 182
  3. Wittenberg, R., Sharpin, L., McCormick, B., & Hurst, J. (2014). Understanding emergency hospital admission of older people, Centre for Health Service Economics & Organisation (CHSEO)
  4. Rowe, T. A., & Juthani-Mehta, M. (2014). Diagnosis and management of urinary tract infection in older adults. Infectious disease clinics of North America, 28(1), 75.
  5. Infectious diseases, 2021, Center for Strategic and International Studies (CSIS), May, 2021).
  6. Salvatore S, Cattoni E, Siesto G, Serati M, Sorice P, Torella M (June 2011). "Urinary tract infections in women". European Journal of Obstetrics, Gynecology, and Reproductive Biology. 156 (2):
  7. Cleveland clinic, overview urinary tract infection, 2020, available at: https://my.clevelandclinic.org/health/diseases/9135-urinary-tract-infections
  8. JJustad, (2010). Best Practice Guidelines: 1, Urinary Tract Infections.
  9. Najar, M. S., Saldanha, C. L., & Banday, K. A. (2009). Approach to urinary tract infections. Indian journal of nephrology, 19(4), 129.
  10. Vasudevan, R. (2014). Urinary tract infection: an overview of the infection and the associated risk factors. J Microbiol Exp, 1(2), 00008
  11. Rowe, T. A., & Juthani-Mehta, M. (2014). Diagnosis and management of urinary tract infection in older adults. Infectious disease clinics of North America, 28(1), 75.
  12. Abraham, Soman N.; Miao, Yuxuan (October 2015). "The nature of immune responses to urinary tract infections". Nature Reviews. Immunology. 15 (10): 655–663
  13. Nicolle, L. E. (2008). Uncomplicated urinary tract infection in adults including uncomplicated pyelonephritis. Urologic Clinics of North America, 35(1), 1-12.
  14. Sievert, Ricks, Edwards, Schneider, Patel, Srinivasan, & Fridkin, (2013). Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009–2010. Infection control and hospital epidemiology, 34(1), 1-14
  15. Bagshaw, SM; Laupland, KB (February 2006). "Epidemiology of intensive care unit-acquired urinary tract infections". Current Opinion in Infectious Diseases. 19 (1)
  16. Lane, D. R., & Takhar, S. S. (2011). Diagnosis and management of urinary tract infection and pyelonephritis. Emergency medicine clinics, 29(3), 539-552.
  17. Brill, JR (1 April 2010). "Diagnosis and treatment of urethritis in men". American Family Physician. 81 (7): 873–8.]
  18. Smelov, V., Naber, K., & Johansen, T. E. B. (2016). Improved classification of urinary tract infection: future considerations. European Urology Supplements, 15(4), 71-80.
  19. National Institute for Health and Care Excellence (NICE), (2018), UTI (lower): antimicrobial prescribing, Available at: https://www.nice.org.uk/guidance/ng109/resources/visual-summary-pdf-6544021069
  20. Scholes, D., Hooton, TM. Roberts, PL., Stapleton, AE. Gupta, K., and Stamm, WE (2000). Risk factors for recurrent urinary tract infection in young women, J.Infect.Dis, 182, 1177-1182.
  21. Dason, S., Dason, J. T., & Kapoor, A. (2011). Guidelines for the diagnosis and management of recurrent urinary tract infection in women. Canadian Urological Association Journal, 5(5), 316.
  22. Cleveland clinic, overview urinary tract infection, 2020, available at: https://my.clevelandclinic.org/health/diseases/9135-urinary-tract-infections.
  23. Schiffert Health Center (SHC), Lower Urinary Tract Infection, Revised March 2020, Available athttps://healthcenter.vt.edu/content/dam/healthcenter_vt_edu/assets/docs/UTI.pdf
  24. Michael H. Augenbraun, William M. McCormack, in Mandell, Douglas, and Bennett’s, (2015). Principles and Practice of Infectious Diseases (Eighth Edition).
  25. Nickel, J. C. (2005). Practical management of recurrent urinary tract infections in premenopausal women. Reviews in Urology, 7(1), 11.
  26. Zhanel, G. G., Zhanel, M. A., & Karlowsky, J. A. (2020). Oral and intravenous fosfomycin for the treatment of complicated urinary tract infections. Canadian Journal of Infectious Diseases and Medical Microbiology, 2020.
  27. Detweiler, K., Mayers, D., & Fletcher, S. G. (2015). Bacteruria and urinary tract infections in the elderly. Urologic Clinics, 42(4), 561-568.
  28. Wagenlehner, F. M., Vahlensieck, W., Bauer, H. W., Weidner, W., Piechota, H. J., & Naber, K. G. (2013). Prevention of recurrent urinary tract infections. Minerva urologica e nefrologica= The Italian journal of urology and nephrology, 65(1), 9-20.
  29. Pallett, A., & Hand, K. (2010). Complicated urinary tract infections: practical solutions for the treatment of multiresistant Gram-negative bacteria. Journal of antimicrobial chemotherapy, 65(suppl_3), iii25-iii33.
  30. Shepherd, A. K., & Pottinger, P. S. (2013). Management of urinary tract infections in the era of increasing antimicrobial resistance. Medical Clinics, 97(4), 737-757.
  31. Colgan, R., & Williams, M. (2011). Diagnosis and treatment of acute uncomplicated cystitis. American family physician, 84(7), 771-776.
  32. Kutlay S, Kutlay B, Karaahmetoglu O, AKC, Erkayas. Prevalence,detection and treatment of asymptomatic bacteriuria in a Turkish obstetric population: J Reprod Med. 2003; 48(8):627-30
  33. Jacociunas LV, Picoli SU. Avaliação de infecção urinária em gestantes no primeiro trimestre de gravidez. Rev Bras Anal Clin. 2007; 39:55-7.
  34. Renko M, Tapanainen P, Tossavainen P, Pokka T, Uhari M, Diabetes care, 2011; 34: 230-5.
  35. Geerlings SE, Ronal P. Stolk , Marielle J.L Camps, Paetrick M. Netten, Joost B.L Hoekstra ,K.Paul Bouter, Bert Bravenboer, J.Theo Collet, Arjen R. Jansz, Andy I.M Hoepelman, Diabetic Care, 2000; 23 (6):744-9.
  36. Foxman, B. et al. (2000) „Risk factors for second urinary tract infection among college women‟, Am. J. Epidemiol., 151, pp. 1194–1205.
  37. Scholes, D., Hooton, T.M., Roberts, P.L., Gupta, K., Stapleton, A.E., S. W. (2005) „Risk factors associated with acute pyelonephritis in healthy women‟, Ann. Intern. Med., (142), p. 20–27.
  38. Gupta K, Hillier SL, Hooton TM, Roberts PL, Stamm WE: Effects of contraceptive method on the vaginal microbial flora: a prospective evaluation. J. Infect. Dis., 2000; 181, 595–601
  39. Muramatsu, K. et al. (2018) „Efficacy of antimicrobial catheters for prevention of catheter-associated urinary tract infection in acute cerebral nfarction‟, Journal of epidemiology, 28(1), pp. 54–58. doi: 10.2188/jea.
  40. Hu, F. et al. (2018) „Gender differences in inappropriate use of urinary catheters among hospitalized older patients‟, Journal of Women and Aging. Routledge, 00(00), pp. 1–11. doi: 10.1080/08952841.2018.1423918.
  41. Uckay, I., Sax, H., Gayet-Ageron, A., et al. (2013) „High proportion of healthcare-associated urinary tract infection in the absence of prior exposure to urinary catheter: a cross-sectional study.‟, Antimicrob Resist Infect Control, 2, p. 5.
  42. John L Brusch, 2020, What are the risk factors for urinary tract infection (UTI)? Medscape, available online at  : https://www.medscape.com/answers/233101-3211/what-are-the-risk-factors-for-urinary-tract-infection-uti
  43. Baisley K, Changalucha J, Weiss HA, Mugeye K, Everett D, et al., Bacterial vaginosis in female facility workers in north-western Tanzania: prevalence and risk factors. Sexually Transmitted Infections, 2009; 85: 370–375.
  44. Adinma ED, Adinma JI. Perceptions and practices on menstruation amongst Nigerian secondary school girls. African Journal of Reproductive Health, 2008; 12: 74–83.
  45. Aniebue UU, Aniebue PN, Nwankwo TO. The impact of pre-menarcheal training on menstrual practices and hygiene of Nigerian school girls. Pan Afr Med J, 2009; 2: 9.
  46. Demba E, Morison L, Loeff MSvd, Awasana AA, Gooding E, et al., Bacterial vaginosis, vaginal flora patterns and vaginal hygiene practices in patients presenting with vaginal discharge syndrome in The Gambia, West Africa. BMC Infectious Diseases, 2005
  47. Dasgupta A, Sarkar M. Menstrual hygiene: how hygienic is the adolescent girl? Indian Journal of Community Medicine. 2008; 33: 77–80
  48. Vasudevan, R. (2014). Urinary tract infection: an overview of the infection and the associated risk factors. J Microbiol Exp, 1(2), 00008.
  49. Abraham, Soman N.; Miao, Yuxuan (October 2015). "The nature of immune responses to urinary tract infections". Nature Reviews. Immunology. 15 (10): 655–663
  50. Pirofski, L. A., & Casadevall, A. (2012). Q&A: What is a pathogen? A question that begs the point. BMC biology, 10(1), 1-3.
  51. Balloux, F., & van Dorp, L. (2017). Q&A: What are pathogens, and what have they done to and for us?. BMC biology, 15(1), 1-6.
  52. Sender, R., Fuchs, S., & Milo, R. (2016). Revised estimates for the number of human and bacteria cells in the body. bioRxiv 036103.
  53. Al-mohanna, M, T., Pathogenesis of Bacterial Infection, Book, (2016), available online at: https://www.researchgate.net/publication/315804648_Pathogenesis_of_Bacterial_Infectin
  54. P. Desmarchelier, N. Fegan, (2002). Escherichia coli, Encyclopedia of Dairy Sciences, available at:https://www.sciencedirect.com/topics/agricultural-and-biological-sciences/escherichia-coli
  55. Martinez-Medina, M. (2021). Special Issue: Pathogenic Escherichia coli: Infections and Therapies. Antibiotics 2021, 10, 112.
  56. Gorrie, C. L. et al. (2018) „Antimicrobial resistant Klebsiella pneumoniae carriage and infection in specialized geriatric care wards linked to acquisition in the referring hospital.‟, Clinical Infectious Diseases, pp. 1–30. doi: 10.1093/cid/ciy027/4798841.
  57. John V. Ashurst and Adam Dawson, (2021). Klebsiella Pneumonia, Stat Pearls, available at: https://www.ncbi.nlm.nih.gov/books/NBK519004/
  58. Mahmudunnabi, G. et al. (2018) „Molecular detection and PCR-RFLP analysis using Pst1 and Alu1 of multidrug resistant Klebsiella pneumoniae causing urinary tract infection in women in the eastern part of Bangladesh‟, Journal of Genetic Engineering and Biotechnology. Academy of Scientific Research & Technology, pp. 1–5. doi: 10.1016/j.jgeb.2017.12.004.
  59. Mittal, R., Aggarwal, S., Sharma, S., Chhibber, S., & Harjai, K. (2009). Urinary tract infections caused by Pseudomonas aeruginosa: a minireview. Journal of infection and public health, 2(3), 101-111
  60. Narten, M., Rosin, N., Schobert, M., & Tielen, P. (2012). Susceptibility of Pseudomonas aeruginosa urinary tract isolates and influence of urinary tract conditions on antibiotic tolerance. Current microbiology, 64(1), 7-16.
  61. Joseph Bennington-Castro,(2020),What Is Pseudomonas Aeruginosa? Symptoms, Causes, Diagnosis, Treatment, and Prevention,available online at:https://www.everydayhealth.com/pseudomonas-aeruginosa/
  62. Chen, C. Y., Chen, Y. H., Lu, P. L., Lin, W. R., Chen, T. C., & Lin, C. Y. (2012). Proteus mirabilis urinary tract infection and bacteremia: risk factors, clinical presentation, and outcomes. Journal of Microbiology, Immunology and Infection, 45(3), 228-236.
  63. Schaffer, J. N., & Pearson, M. M. (2017). Proteus mirabilis and urinary tract infections. Urinary Tract Infections: Molecular Pathogenesis and Clinical Management, 383-433.
  64. Davin-Regli, A. (2015). Enterobacter aerogenes and Enterobacter cloacae; versatile bacterial pathogens confronting antibiotic treatment. Frontiers in microbiology, 6, 392.
  65. Ramirez, D., & Giron, M. (2021). Enterobacter infections. StatPearls, available online at: https://www.ncbi.nlm.nih.gov/books/NBK559296/
  66. Kirkcaldy, R. D., Harvey, A., Papp, J. R., Del Rio, C., Soge, O. O., Holmes, K. K., ... & Torrone, E. (2016). Neisseria gonorrhoeae antimicrobial susceptibility surveillance—the gonococcal isolate surveillance project, 27 sites, United States, 2014. Morbidity and Mortality Weekly Report: Surveillance Summaries, 65(7), 1-19.
  67. Mohammd Sbiti., et al. “Neisseria Gonorrhoeae Infections: Biological Diagnosis, Antibiotic Resistance and Treatment". Acta Scientific Microbiology 2.11 (2019): 41-50
  68. Kanafani, Z., & Kanj, S. (2015). Acinetobacter infection: Treatment and prevention. UpToDate.[(accessed on 28 February 2021)].
  69. Fishbain, J., & Peleg, A. Y. (2010). Treatment of Acinetobacter infections. Clinical infectious diseases, 51(1), 79-84.
  70. Kline, K. A., & Lewis, A. L. (2016). Gram-positive uropathogens, polymicrobial urinary tract infection, and the emerging microbiota of the urinary tract. Microbiology spectrum, 4(2), 4-2.
  71. Wagenlehner, F.M., N. K. (2006) „Current challenges in the treatment of complicated urinary tract infections and prostatitis.‟, Clin Microbiol Infect, 12, p. 67–80
  72. Malachowa N, DeLeo FR. 2010. Mobile genetic elements of Staphylococcus aureus. Cell Mol Life Sci 67:3057–3071. Doi: 10.1007/s00018-010-0389-4.
  73. Gilmore B, Hamill T, Gorman S, Jones D. Catheter-based drug–device combination products: an overview. Drug-Device Combination Prod. 2010; 61–92.
  74. Kosmidis CI, Chandrasekar PH. Management of gram-positive bacterial infections in patients with cancer. Leuk Lymphoma. 2012; 53(1):8–18. doi:10.3109/10428194.2011.602770
  75. Hamory BH, Parisi JT, Hutton JP. Staphylococcus epidermidis: a significant nosocomial pathogen. Am J Infect Control? 1987 Apr; 15(2):59-74
  76. Upadhyayula, S., Kambalapalli, M., & Asmar, B. I. (2012). Staphylococcus epidermidis urinary tract infection in an infant. Case reports in infectious diseases, 2012.
  77. Lozano, V., Fernandez, G., Spencer, P. L., Taylor, S. L., & Hatch, R. (2015). Staphylococcus epidermidis in urine is not always benign: a case report of pyelonephritis in a child. The Journal of the American Board of Family Medicine, 28(1), 151-153.
  78. Murray, B E (1990). "The life and times of the Enterococcus". Clinical Microbiology Reviews. 3 (1): 46–65
  79. Crump, J. A., et al. (2015). Epidemiology, clinical presentation, laboratory diagnosis, antimicrobial resistance, and antimicrobial management of invasive salmonella infections.

International Journal of Scientific Research in Science and Technology

Downloads

Published

2022-04-30

Issue

Volume 9, Issue 2, March-April-2022

Section

Research Articles

License

Copyright (c) IJSRST

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

How to Cite

[1]
Rana Thamer Hadi Alkhafaji, M. Jayashankar "Etiological Agents of Urinary Tract Infection (UTI)" International Journal of Scientific Research in Science and Technology(IJSRST), Online ISSN : 2395-602X, Print ISSN : 2395-6011,Volume 9, Issue 2, pp.381-394, March-April-2022. Available at doi : https://doi.org/10.32628/IJSRST22925